Funding Announcements

"Clinical research is broken by data silos,"

"Introducing customers to Business Premium, and providing them with the most valuable licensing, is only the first step. The other is to make sure those licenses stay configured and up to date. Trying to do that across 300 customers is impossible without inforcer"

"This investment is a momentous milestone for the business. Since we founded in 2022, we’ve been high growth and laser-focused on building the best compliance consultancy in the UK, assembling a team dedicated to excellent personal service. We’re delighted to be working alongside BGF, developing a partnership that will allow us to access the funding, experience and expertise we need to take advantage of the opportunities that lie ahead."

"We focused on raising the minimum amount required and selecting investors that bring valuable deep payments industry experience, combined with innovative non-dilutive funding from re:cap"

"We focused on raising the minimum amount required and selecting investors that bring valuable deep payments industry experience, combined with innovative non-dilutive funding from re:cap. We are in a David vs Goliath battle with our larger competitors, where their massive OPEX commitments present a significant opportunity for our nimble, innovative and customer-centric approach. We’ve stayed lean, raised capital in a sustainable non-dilutive way, and delivered products that offer real benefits – there’s more to come in 2025."